811794-94-2

Basic information

• Product Name: 1H-Imidazole, 2-(1-azetidinylmethyl)-
• Synonyms: 1H-Imidazole, 2-(1-azetidinylmethyl)-
• CAS NO: 811794-94-2
• Molecular Formula: C₇H₁₁N₃
• Molecular Weight: 0
• Mol File: 811794-94-2.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1H-Imidazole, 2-(1-azetidinylmethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Imidazole, 2-(1-azetidinylmethyl)-(811794-94-2)
• EPA Substance Registry System: 1H-Imidazole, 2-(1-azetidinylmethyl)-(811794-94-2)

Safety Data

• Hazardous Substances Data: 811794-94-2(Hazardous Substances Data)

Upstream product

• 78797-58-7 azetidine hydrochloride 
• 10111-08-7 2-imidazolecarbaldehyde 

Relevant articles and documents

PYRROLIDINE - 2- ONES AS FACTOR XA INHIBITORS

The invention relates to compounds of formula (I): wherein: R1 represents a group selected from: formula (II), each ring of which optionally contains a further heteroatom N, Z represents an optional substituent halogen, alk represents alkylene or alkenylene, T represents S, O or NH; R2 represents hydrogen, -C1-6alkyl, -C1-3alkylCONRaRb, -C1-3alkylCO2C1-4alkyl, -CO2C1-4alkyl or -C1-3alkylCO2H; Ra and Rb independently represent hydrogen, -C1-6alkyl, or together with the N atom to which they are bonded form a 5-, 6- or 7- membered non-aromatic heterocyclic ring optionally containing an additional heteroatom selected from O, N or S, optionally substituted by -C1-4alkyl, and optionally the S heteroatom is substituted by O, i.e. represents S(O)n; n represents 0-2; X represents phenyl or a 5- or 6- membered aromatic heterocyclic group containing at least one heteroatom selected from O, N or S, each of which is optionally substituted by 0-2 groups selected from: halogen, -C1-4alkyl, -C2-4alkenyl, -CN, -CF3, -NRaRb, -C0-4alkylORe, -C(O)Rf and -C(O)NRaRb; Re represents hydrogen or -C1-6alkyl; Rf represents -C1-6alkyl; Y represents phenyl or a 5- or 6- membered aromatic heterocyclic group containing at least one heteroatom selected from O, N or S, each of which is substituted by a group -C1-2alkylNRcRd. Rc and Rd, together with the nitrogen atom to which they are bonded, form a 4-membered heterocyclic ring optionally substituted by halogen, OH or -OC1-6alkyl, or a 5- or 6- membered non-aromatic heterocyclic ring substituted by OH, -OC1-6alkyl or 1 to 2 halogens, with the proviso that the substituent is not attached to a ring carbon atom adjacent to a heteroatom; and/or pharmaceutically acceptable derivatives thereof. The invention also relates to processes for the preparation of compounds of formula (I), pharmaceutical compositions containing compounds of formula (I) and to the use of compounds of formula (I) in medicine, particularly in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.